Cargando…

Evaluation of Rapid Polymyxin Pseudomonas test in clinical Pseudomonas aeruginosa isolates with various degrees of multidrug resistance

BACKGROUND: Pseudomonas aeruginosa is of great concern among MDR bacteria and rapid and reliable in vitro antibiotic susceptibility testing methods are extremely necessary. Colistin is, in many cases, among the limited useful alternatives for these isolates. Unfortunately, only a few reliable in vit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez-López, Javier, Cortés-Cuevas, José Luis, Díez-Aguilar, María, López-Causapé, Carla, Cantón, Rafael, Morosini, María Isabel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305739/ https://www.ncbi.nlm.nih.gov/pubmed/34316679 http://dx.doi.org/10.1093/jacamr/dlab104

Ejemplares similares

The Versatile Mutational Resistome of Pseudomonas aeruginosa
por: López-Causapé, Carla, et al.
Publicado: (2018)

Low Ciprofloxacin Concentrations Select Multidrug-Resistant Mutants Overproducing Efflux Pumps in Clinical Isolates of Pseudomonas aeruginosa
por: Sanz-García, Fernando, et al.
Publicado: (2022)

Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone
por: López-Causapé, Carla, et al.
Publicado: (2017)

Temperate Bacteriophages (Prophages) in Pseudomonas aeruginosa Isolates Belonging to the International Cystic Fibrosis Clone (CC274)
por: Ambroa, Antón, et al.
Publicado: (2020)

Genome-scale metabolic modeling of responses to polymyxins in Pseudomonas aeruginosa
por: Zhu, Yan, et al.
Publicado: (2018)

The prevalence of Pseudomonas aeruginosa and multidrug resistant Pseudomonas aeruginosa in healthy captive ophidian
por: Sala, Andrea, et al.
Publicado: (2019)

Rapid Phenotypic Convergence towards Collateral Sensitivity in Clinical Isolates of Pseudomonas aeruginosa Presenting Different Genomic Backgrounds
por: Hernando-Amado, Sara, et al.
Publicado: (2022)

Clinically Relevant Concentrations of Polymyxin B and Meropenem Synergistically Kill Multidrug-Resistant Pseudomonas aeruginosa and Minimize Biofilm Formation
por: Wickremasinghe, Hasini, et al.
Publicado: (2021)

Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD
por: Shafiek, Hanaa, et al.
Publicado: (2021)

Risk Factors and Outcomes for Multidrug Resistant Pseudomonas aeruginosa Infection in Immunocompromised Patients
por: Hernández-Jiménez, Pilar, et al.
Publicado: (2022)

Effects of Inhaled Corticosteroids on the Innate Immunological Response to Pseudomonas aeruginosa Infection in Patients with COPD
por: Cerón-Pisa, Noemi, et al.
Publicado: (2022)

Effect of methylglyoxal on multidrug-resistant Pseudomonas aeruginosa
por: Hayashi, Katsuhiko, et al.
Publicado: (2014)

Multidrug resistant Pseudomonas aeruginosa in Estonian hospitals
por: Telling, Kaidi, et al.
Publicado: (2018)

Comparative Analysis of Peptidoglycans From Pseudomonas aeruginosa Isolates Recovered From Chronic and Acute Infections
por: Torrens, Gabriel, et al.
Publicado: (2019)

Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis
por: Sastre-Femenia, Miquel Àngel, et al.
Publicado: (2023)

Intrathecal (intraventricular) polymyxin B in the treatment of patients with meningoencephalitis by Acinetobacter baumanii and Pseudomonas aeruginosa
por: Macedo, SK, et al.
Publicado: (2011)

Comparative Metabolomics and Transcriptomics Reveal Multiple Pathways Associated with Polymyxin Killing in Pseudomonas aeruginosa
por: Han, Mei-Ling, et al.
Publicado: (2019)

Ceftazidime/Avibactam versus Polymyxin B in the Challenge of Carbapenem-Resistant Pseudomonas aeruginosa Infection
por: Chen, Juan, et al.
Publicado: (2022)

MvfR Controls Tolerance to Polymyxin B by Regulating rfaD in Pseudomonas aeruginosa
por: Yang, Fan, et al.
Publicado: (2023)

Synergistic Effect between Usnic Acid and Polymyxin B against Resistant Clinical Isolates of Pseudomonas aeruginosa
por: da Costa Júnior, Sérgio Dias, et al.
Publicado: (2020)

Mutation Analysis in Regulator DNA-Binding Regions for Antimicrobial Efflux Pumps in 17,000 Pseudomonas aeruginosa Genomes
por: Pérez-Vázquez, María, et al.
Publicado: (2023)

Carbapenem Combinations for Infections Caused by Carbapenemase-Producing Pseudomonas aeruginosa: Experimental In Vitro and In Vivo Analysis
por: Herrera-Espejo, Soraya, et al.
Publicado: (2022)

MexXY multidrug efflux system of Pseudomonas aeruginosa
por: Morita, Yuji, et al.
Publicado: (2012)

Emergence and Spread of Epidemic Multidrug-Resistant Pseudomonas aeruginosa
por: Miyoshi-Akiyama, Tohru, et al.
Publicado: (2017)

Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
por: Kunz Coyne, Ashlan J., et al.
Publicado: (2022)

1295. Activity of SPR206, a Polymyxin B Derivative, Compared to Colistin Alone and in Combination Against Multidrug-Resistant Pseudomonas aeruginosa Strains
por: Abdul-Mutakabbir, Jacinda C, et al.
Publicado: (2020)

Prevalence and Molecular Characteristics of Polymyxin-Resistant Pseudomonas aeruginosa in a Chinese Tertiary Teaching Hospital
por: Xiao, Chenlu, et al.
Publicado: (2022)

Integrated metabolomic and transcriptomic analyses of the synergistic effect of polymyxin–rifampicin combination against Pseudomonas aeruginosa
por: Mahamad Maifiah, Mohd Hafidz, et al.
Publicado: (2022)

Mechanisms of action and antimicrobial activity of ceftobiprole
por: Morosini, María-Isabel, et al.
Publicado: (2019)

Carbapenem Susceptibility and Multidrug-Resistance in Pseudomonas aeruginosa Isolates in Egypt
por: Hashem, Hany, et al.
Publicado: (2016)

S33.1 Multidrug-resistant Acinetobacter baumanii and Pseudomonas aeruginosa
Publicado: (2005)

Exposure of Pseudomonas aeruginosa to Cinnamaldehyde Selects Multidrug Resistant Mutants
por: Tetard, Alexandre, et al.
Publicado: (2022)

Clonal Dissemination, Emergence of Mutator Lineages and Antibiotic Resistance Evolution in Pseudomonas aeruginosa Cystic Fibrosis Chronic Lung Infection
por: López-Causapé, Carla, et al.
Publicado: (2013)

Effective Antibiotics in Combination against Extreme Drug-Resistant Pseudomonas aeruginosa with Decreased Susceptibility to Polymyxin B
por: Lim, Tze-Peng, et al.
Publicado: (2011)

Synergistic Combination of Polymyxin B and Enrofloxacin Induced Metabolic Perturbations in Extensive Drug-Resistant Pseudomonas aeruginosa
por: Lin, Yu-Wei, et al.
Publicado: (2019)

1219. Unfavorable Clinical Outcomes with Polymyxins Compared to Ceftolozane/Tazobactam for the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa
por: Howard-Anderson, Jessica, et al.
Publicado: (2021)

2180. Pseudomonas aeruginosa epidemic high-risk clones and their association with multidrug-resistant
por: Zurita, Jeannete, et al.
Publicado: (2023)

Prophage identification and molecular analysis in the genomes of Pseudomonas aeruginosa strains isolated from critical care patients
por: González de Aledo, Manuel, et al.
Publicado: (2023)

Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins
por: Torrens, Gabriel, et al.
Publicado: (2019)

Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules
por: Schneider-Futschik, Elena K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_afir5e85aktelcoasulcnqbme7